Shubhra Rastogi

Shubhra Rastogi is a seasoned biomedical researcher currently serving as a Senior Translational Research Scientist at Day One Biopharmaceuticals since September 2022. Prior experience includes roles as a Preclinical Scientist at Triphase Accelerator Corporation, where efforts were led to develop inhibitors for the epigenetic pathway in leukemia. At the University of California San Diego, Shubhra held the positions of Project Scientist and Postdoctoral Scholar, overseeing research initiatives and discovering significant functions of Abl in oxidative stress and microRNA interactions. Additionally, at the University of Dundee, funding was secured from Teva Pharmaceuticals for research on the chemotherapeutic drug Bendamustine hydrochloride. Academic credentials include a PhD in Cancer Biology from the University of Dundee, an MSc in Biotechnology from the University of Abertay Dundee, and a certificate from the MICROMBA program at the University of California, San Diego.